
Deborah Crouch
Examiner (ID: 4504, Phone: (571)272-0727 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1804, 1819, 2899, 1632, 3725 |
| Total Applications | 1439 |
| Issued Applications | 694 |
| Pending Applications | 237 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6626061
[patent_doc_number] => 20100172863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'Enhanced medical implant'
[patent_app_type] => utility
[patent_app_number] => 12/655633
[patent_app_country] => US
[patent_app_date] => 2010-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 21036
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20100172863.pdf
[firstpage_image] =>[orig_patent_app_number] => 12655633
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/655633 | Enhanced medical implant comprising disrupted tooth pulp and tooth particles | Jan 3, 2010 | Issued |
Array
(
[id] => 6467900
[patent_doc_number] => 20100146654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'UNACTIVATED OOCYTES AS CYTOPLAST RECIPIENTS FOR NUCLEAR TRANSFER'
[patent_app_type] => utility
[patent_app_number] => 12/647316
[patent_app_country] => US
[patent_app_date] => 2009-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6854
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20100146654.pdf
[firstpage_image] =>[orig_patent_app_number] => 12647316
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647316 | UNACTIVATED OOCYTES AS CYTOPLAST RECIPIENTS FOR NUCLEAR TRANSFER | Dec 23, 2009 | Abandoned |
Array
(
[id] => 9009577
[patent_doc_number] => 08524875
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Nucleic acids encoding SOX10 promoter and methods to isolate SOX10 expressing cells'
[patent_app_type] => utility
[patent_app_number] => 12/645431
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 151
[patent_no_of_words] => 17054
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12645431
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/645431 | Nucleic acids encoding SOX10 promoter and methods to isolate SOX10 expressing cells | Dec 21, 2009 | Issued |
Array
(
[id] => 6289719
[patent_doc_number] => 20100158868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'Use of Fetal Cells for the Treatment of Genetic Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/643639
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14479
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20100158868.pdf
[firstpage_image] =>[orig_patent_app_number] => 12643639
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/643639 | Use of Fetal Cells for the Treatment of Genetic Diseases | Dec 20, 2009 | Abandoned |
Array
(
[id] => 7811513
[patent_doc_number] => 08134044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-13
[patent_title] => 'Transgenic reptiles'
[patent_app_type] => utility
[patent_app_number] => 12/641847
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7306
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/134/08134044.pdf
[firstpage_image] =>[orig_patent_app_number] => 12641847
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/641847 | Transgenic reptiles | Dec 17, 2009 | Issued |
Array
(
[id] => 6320289
[patent_doc_number] => 20100196332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Generation of brachial, thoracic and lumbar spinal motor neurons from embryonic stem cells in the absence of all-trans retinoic acid supplement'
[patent_app_type] => utility
[patent_app_number] => 12/653217
[patent_app_country] => US
[patent_app_date] => 2009-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 28130
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196332.pdf
[firstpage_image] =>[orig_patent_app_number] => 12653217
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/653217 | Caudal motor neuron derived from embryonic stem cells under conditions essentially free of any retinoid | Dec 8, 2009 | Issued |
Array
(
[id] => 8968138
[patent_doc_number] => 08506948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-13
[patent_title] => 'UCB-MSCs comprising a tumor suppressor gene reduce the size of an IL-8 or GRO-αexpressing tumor'
[patent_app_type] => utility
[patent_app_number] => 12/633622
[patent_app_country] => US
[patent_app_date] => 2009-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 27495
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12633622
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/633622 | UCB-MSCs comprising a tumor suppressor gene reduce the size of an IL-8 or GRO-αexpressing tumor | Dec 7, 2009 | Issued |
Array
(
[id] => 6506442
[patent_doc_number] => 20100210530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'EXTRACELLULAR MATRIX COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/632721
[patent_app_country] => US
[patent_app_date] => 2009-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 23837
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20100210530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12632721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/632721 | Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells | Dec 6, 2009 | Issued |
Array
(
[id] => 6202406
[patent_doc_number] => 20110065192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'Embryonic stem cell line and method for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 12/591505
[patent_app_country] => US
[patent_app_date] => 2009-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10301
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065192.pdf
[firstpage_image] =>[orig_patent_app_number] => 12591505
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/591505 | Embryonic stem cell line and method for preparing the same | Nov 19, 2009 | Abandoned |
Array
(
[id] => 7784202
[patent_doc_number] => 20120045758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'IMPRINTING IN VERY SMALL EMBRYONIC-LIKE (VSEL) STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/129352
[patent_app_country] => US
[patent_app_date] => 2009-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 20320
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20120045758.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129352
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129352 | IMPRINTING IN VERY SMALL EMBRYONIC-LIKE (VSEL) STEM CELLS | Nov 15, 2009 | Abandoned |
Array
(
[id] => 8577271
[patent_doc_number] => 08343480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Administration of stem or progenitor cells to a joint to enhance recovery from joint surgery'
[patent_app_type] => utility
[patent_app_number] => 12/617042
[patent_app_country] => US
[patent_app_date] => 2009-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5924
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12617042
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/617042 | Administration of stem or progenitor cells to a joint to enhance recovery from joint surgery | Nov 11, 2009 | Issued |
Array
(
[id] => 9582025
[patent_doc_number] => 08772028
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using'
[patent_app_type] => utility
[patent_app_number] => 13/127490
[patent_app_country] => US
[patent_app_date] => 2009-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 33820
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13127490
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127490 | CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using | Nov 5, 2009 | Issued |
Array
(
[id] => 6230384
[patent_doc_number] => 20100184227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'PLURIPOTENT STEM CELLS OBTAINED BY NON-VIRAL REPROGRAMMING'
[patent_app_type] => utility
[patent_app_number] => 12/605220
[patent_app_country] => US
[patent_app_date] => 2009-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6606
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184227.pdf
[firstpage_image] =>[orig_patent_app_number] => 12605220
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/605220 | OCT4 and SOX2 with SV40 T antigen produce pluripotent stem cells from primate somatic cells | Oct 22, 2009 | Issued |
Array
(
[id] => 9355104
[patent_doc_number] => 08673637
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Human multipotent germ line stem cells expressing a germ line marker and a pluripotency marker produced by co-culture of testicular tissue'
[patent_app_type] => utility
[patent_app_number] => 12/589179
[patent_app_country] => US
[patent_app_date] => 2009-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 38
[patent_no_of_words] => 10831
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12589179
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/589179 | Human multipotent germ line stem cells expressing a germ line marker and a pluripotency marker produced by co-culture of testicular tissue | Oct 15, 2009 | Issued |
Array
(
[id] => 6447612
[patent_doc_number] => 20100105100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'MULTIPOTENT/PLURIPOTENT CELLS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/580216
[patent_app_country] => US
[patent_app_date] => 2009-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 115769
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105100.pdf
[firstpage_image] =>[orig_patent_app_number] => 12580216
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/580216 | MULTIPOTENT/PLURIPOTENT CELLS AND METHODS | Oct 14, 2009 | Abandoned |
Array
(
[id] => 6486704
[patent_doc_number] => 20100093077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'EXTRACELLULAR MATRIX COMPONENTS FOR EXPANSION OR DIFFERENTIATION OF HEPATIC PROGENITORS'
[patent_app_type] => utility
[patent_app_number] => 12/572711
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 9335
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093077.pdf
[firstpage_image] =>[orig_patent_app_number] => 12572711
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/572711 | EXTRACELLULAR MATRIX COMPONENTS FOR EXPANSION OR DIFFERENTIATION OF HEPATIC PROGENITORS | Oct 1, 2009 | Abandoned |
Array
(
[id] => 8312571
[patent_doc_number] => 20120189595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'INDUCED PLURIPOTENT STEM CELLS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/120727
[patent_app_country] => US
[patent_app_date] => 2009-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12979
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120727
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120727 | INDUCED PLURIPOTENT STEM CELLS AND METHODS OF USE | Sep 24, 2009 | Abandoned |
Array
(
[id] => 7686072
[patent_doc_number] => 20100120069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'MULTIPOTENT/PLURIPOTENT CELLS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/564836
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 115773
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120069.pdf
[firstpage_image] =>[orig_patent_app_number] => 12564836
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/564836 | MULTIPOTENT/PLURIPOTENT CELLS AND METHODS | Sep 21, 2009 | Abandoned |
Array
(
[id] => 6352175
[patent_doc_number] => 20100021999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same'
[patent_app_type] => utility
[patent_app_number] => 12/585646
[patent_app_country] => US
[patent_app_date] => 2009-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15358
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021999.pdf
[firstpage_image] =>[orig_patent_app_number] => 12585646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/585646 | Culture of human embryonic stem cells on a matrix with TGFB1 and bFGF | Sep 20, 2009 | Issued |
Array
(
[id] => 9964607
[patent_doc_number] => 09012217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-21
[patent_title] => 'Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells'
[patent_app_type] => utility
[patent_app_number] => 12/561235
[patent_app_country] => US
[patent_app_date] => 2009-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31586
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12561235
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/561235 | Benzimidazole compounds differentiate a mammalian stem cell into mesodermal or cardiomyocyte cells | Sep 15, 2009 | Issued |